hydroxyurea has been researched along with fedratinib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baccarani, M; Catani, L; Cavo, M; Palandri, F; Polverelli, N; Vianelli, N | 1 |
1 other study(ies) available for hydroxyurea and fedratinib
Article | Year |
---|---|
Ruxolitinib- but not fedratinib-induced extreme thrombocytosis: the combination therapy with hydroxyurea and ruxolitinib is effective in reducing platelet count and splenomegaly/constitutional symptoms.
Topics: Antisickling Agents; Humans; Hydroxyurea; Male; Middle Aged; Nitriles; Platelet Count; Pyrazoles; Pyrimidines; Pyrrolidines; Splenomegaly; Sulfonamides; Thrombocytosis | 2015 |